drugset / Trial / NCT02003495
Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this observer-blind study is to evaluate the safety, reactogenicity and immunogenicity of Meninggococcal (A,C,Y and W135) Conjugate Vaccine in 2 months to 6 years-old children.
Timeline
- Start
- 2013-10
- Primary completion
- 2014-08
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hib | Vaccine | 0.5 ml | Intramuscular |
| Comparator | MCV-AC | Vaccine | 0.5 ml | Intramuscular |
| Subject | MCV-ACYW135 | Vaccine | 0.5 ml | Intramuscular |
| Comparator | MPV-A | Vaccine | 0.5 ml | Intramuscular |
| Comparator | MPV-ACYW135 | Vaccine | 0.5 ml | Intramuscular |